FORM 3A - Director/Chief Executive Notice - Interests in Shares of Listed Corporation
 
Form Serial Number: DA20260508E00303
1. Date of relevant event: 31/03/2026
(dd/mm/yyyy)
2. Date when director became aware of the relevant event/ interest in the shares (if later):
(dd/mm/yyyy)
3. Stock code: 02563
4. Name of listed corporation: Beijing Biostar Pharmaceuticals Co., Ltd. - B - H Shares 
5. Class of shares: H Shares 
6. Number of issued shares in class: 364,588,000
7. Name of director (English) as printed on HKID Card/Passport:
(Surname) Tang
(Other names) Li
10. Name of director (Chinese): 唐莉 
11. Chinese Character Code as printed on HKID Card:
 
24. Details of relevant event:
  Brief description of relevant event Capacity in which shares were/are held Number of shares bought/sold or involved Currency of transaction On Exchange Off Exchange
Before relevant event After relevant event Highest price (per share) Average price (per share) Average consideration (per share) Consideration code
Long position 
1110The number of shares in which you are interested has increased because:
you were placed the shares as a placee under a top-up placing
 
 
2501Other (you must describe the capacity in the Supplementary Information box)
 		 57,830,299         
 
Short position 
 
 
 		            
 
25. Total shares in listed corporation immediately before the relevant event:
 Total number of sharesPercentage figure (%)
Long position45,304,51520.90
 
26. Total shares in listed corporation immediately after the relevant event:
 Total number of sharesPercentage figure (%)
Long position103,134,81428.29
 
27. Capacity in which interests disclosed in Box 26 are held:
Code describing capacityNumber of shares
2201Interest of corporation controlled by you
Long position99,336,297
2101Beneficial owner
Long position3,592,932
2202Interest of your spouse
Long position205,585
 
28. Further information in derivative interests in listed corporation :
Derivatives code Exercise period (dd/mm/yyyy) Consideration - if derivatives granted by listed corporation Number of shares
  BeginsEndsCurrencyPrice for grantCurrencyExercise priceCurrencyPrice on assignment 
           
 
29. Further information in relation to interests of children under 18 and/or spouse:
Child/SpouseName of child/spouseNumber of shares
SpouseQiu Rongguo
Long position123,351
 
30. Further information in relation to interests of corporations controlled by Director:
Name of controlled corporationAddress and place of incorporationName of controlling person% controlDirect interest (Y/N)Number of shares
Baygen QT Inc.The Naaman's Building Suite 206, 3501 Silverside Rd, Wilmington (New Castle County), Delaware 19810Tang Li6.50Y
Long position40,505,885
Short position0
珠海京蓉昊缘投资合伙企业（有限合伙）中国珠海市横琴新区下村38号101单元Tang Li51.00Y
Long position20,392,815
Short position0
珠海华锦昊缘企业管理合伙企业（有限合伙）中国珠海市横琴新区下村40号三楼Tang Li72.17Y
Long position19,220,863
Short position0
珠海华欣昊缘商业管理合伙企业(有限合伙)中国珠海市横琴新区下村45号五楼Tang Li85.18Y
Long position14,002,034
Short position0
珠海华蓉昊缘企业管理合伙企业(有限合伙)珠海市横琴上村153号第五层Tang Li34.57Y
Long position5,000,724
Short position0
北京北进缘科技有限公司北京市北京经济技术开发区荣华中路10号1幢25层2501-A-5(集群注册)Tang Li51.00Y
Long position213,976
Short position0
 
31. Further information in relation to interests held by Director jointly with another person:
Name of joint shareholderAddressNumber of shares
 
 
32. Further information from a director who is a trustee, or beneficiary of a trust, or a person who has set up a Discretionary Trust:
Names of TrustAddressStatus codeNumber of shares
  
 
33. Further information from a party to an agreement under Section 317 (Please see Notes for further information required):
Names of other partiesAddressNumber of shares
 
Total number of shares in which a director is interested under sections 317 and 318
 
34. Supplementary information: 所涉及股份數目共計57,830,299，其中55,551,189來自所控製的法團的權益，2,155,759為實益擁有人的權益，123,351為配偶的權益。
35. Log/Serial Number of the previous form:
36. Number of concert party document(s) under section 317 attached/uploaded:
Date of filing this Form 3A: 08/05/2026
(dd/mm/yyyy)